Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs

Bibliographic Details
Main Authors:	Pugazhenthan Thangaraju, Sajitha Venkatesan
Format:	Article
Language:	English
Published:	Wolters Kluwer 2017-01-01
Series:	Chinese Medical Journal
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=15;spage=1889;epage=1889;aulast=Thangaraju

Similar Items

Reply to Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Kyoung-Woo Seo, et al.
Published: (2017-01-01)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
by: Pugazhenthan Thangaraju, et al.
Published: (2021-08-01)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022-11-01)

Ebola drug trial: a ray of hope
by: Shobanbabu Varthya, et al.
Published: (2019-12-01)

Dünya Sağlık Örgütünün 2019'da küresel sağlığa tehdit ettiğini belirttiği on tehditten biri: Antimikrobiyal direnç
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-09-01)

Cüzzamın yeniden alevlenmesine yönelik mücadele stratejileri: Vurgulanması gereken noktalar
by: Sajitha VENKATESAN, et al.
Published: (2019-12-01)

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-06-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

De novo histoid leprosy - Further points of focus
by: Sajitha Venkatesan, et al.

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Leprosy in Children: Needs for Active Intervention
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Clofazimine induced methemoglobinemia –Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Leprosy reactions: Earlier diagnosis leads to more effective treatment
by: Pugazhenthan Thangaraju, et al.
Published: (2020-03-01)

Current treatment guideline by the World Health Organization against leprosy: A positive focus
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Medical residents: Research and publication priorities/confusions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Government of India initiative against leprosy—We should be aware
by: Sajitha Venkatesan, et al.
Published: (2019-01-01)

Nonsteroid anti-inflammatory drugs
by: Wiliam Habib Chahade, et al.
Published: (2008-03-01)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
by: Pugazhenthan Thangaraju, et al.
Published: (2023-01-01)

Nightmares and Mirtazapine—Time to be vigilant
by: Sree Sudha TY, et al.
Published: (2021-09-01)

Problems of prescribing nonsteroidal anti-inflammatory drugs for reproductive-aged women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)

Health strategy in South State of India – Towards older people
by: Pugazhenthan Thangaraju, et al.
Published: (2023-01-01)

Chloroquine induced utricaria—A detailed history helps
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Decentralisation of healthcare system due to COVID-19 and its impact on hospital based laboratories - Pandemic panic patients’ reflection?
by: Jayagandan Jayamani, et al.
Published: (2020-10-01)

Nonsteroidal anti-inflammatory drugs and the heart.
by: Patrono, C, et al.
Published: (2014)

Nonsteroidal anti‐inflammatory drugs and pharyngitis
by: Stuart B Mazzone, et al.
Published: (2022-12-01)

Nonsteroidal Anti-Inflammatory Drugs and the Kidney
by: Walter H. Hörl
Published: (2010-07-01)

Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
by: Pugazhenthan Thangaraju, et al.
Published: (2023-01-01)

Leprosy - the current target in national programmes
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Curcumin and fungal infection – commonly available herbs for common female infection
by: Shoban Babu Varthya, et al.
Published: (2020-01-01)

Eosinophilia as an adverse drug reaction secondary to thalidomide therapy in Lepra type 2 reactions: a mandate responsibility
by: Deeptanshu Nirmal Chandu, et al.
Published: (2019-12-01)

Effects of nonsteroidal anti-inflammatory drugs on hearing
by: Oğuz Güçlü, et al.
Published: (2012-03-01)

Benefits of liposomal nonsteroid-anti-inflammatory drugs
by: Marković Srđan Z., et al.
Published: (2022-01-01)

BIOPHARMACEUTICAL PROPERTIES OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
by: Y. I. Kulinich
Published: (2022-12-01)

Nonsteroidal anti-inflammatory drugs in therapy for osteoarthrosis
by: V. V. Badokin
Published: (2009-03-01)

Enteropathy induced by nonsteroid anti-inflammatory drugs
by: A E Karateev, et al.
Published: (2004-02-01)

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
by: Brown, J, et al.
Published: (2017)

Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk.
by: Moore, R, et al.
Published: (2014)

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.
by: Allen, C, et al.
Published: (2009)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
by: van Staa, T, et al.
Published: (2000)